BGI Genomics Monthly Spotlight - January 2024
BGI Genomics
BGI Genomics, based in China, is the world’s leading provider of genetic tests and sequencing services.
Driving Health Outcomes through Precision Medicine Applications | Biospectrum Asia
In a recent interview with BioSpectrum Asia, Jeremy (Sujie) cao, General Manager of BGI Genomics Southeast Asia, delves into the company's accomplishments and future growth trajectory.
Screen Early to Detect Cancers, Experts Urge | China Daily
To advance the cause of global cancer prevention,?China Daily Hong Kong invited experts like Shida Zhu, VP of Precision Medicine at BGI Genomics to emphasize how early screening can detect cancers before symptoms arise.
How Clinical Whole Exome Sequencing Helped 3-Year-Old Kosta: Patient's Voice
Find out about little Kosta Le?evi? and the importance of cWES in understanding rare genetic conditions. This little fighter's struggle for a better life and his family's unwavering commitment are an inspiration to us all.
Enhancing Non-Invasive Early Detection of Gestational Diabetes with cfDNA Sequencing
A BGI Genomics Team-led study recently released published on Briefings in Bioinformatics introduces a non-invasive method using cfDNA sequencing and deep learning, with an impressive 93.5% accuracy in detecting Gestational Diabetes.
Innovative Reads, Indeed! What Scientists are Reading in 2024
Dive into the minds of innovators! Explore what's on scientists' bookshelves lately. Check out the BGI Genomics team curated column “Innovative Reads, Indeed!” for acclaimed and recently released books on gene, cancer and immunology